#BEGIN_DRUGCARD DB03199

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C31H37NO11

# Chemical_IUPAC_Name:
methyl (1S,2R,4S)-4-{[(2S,4S,5R,6S)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]oxy}-2-ethyl-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
4-Methoxy-E-Rhodomycin T

# HET_ID:
ERT

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C31H37NO11/c1-7-31(39)12-17(43-18-11-15(32(3)4)25(33)13(2)42-18)20-21(24(31)30(38)41-6)29(37)22-23(28(20)36)27(35)19-14(26(22)34)9-8-10-16(19)40-5/h8-10,13,15,17-18,24-25,33,36-37,39H,7,11-12H2,1-6H3/t13-,15-,17-,18+,24+,25-,31+/m0/s1

# InChI_Key:
InChIKey=XSSVYBYWQBNYOH-AEBUBZPMSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3199

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
599.6256

# Molecular_Weight_Mono:
599.236661031

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1TW2

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
2.22

# Predicted_LogS:
-3.1

# Predicted_Water_Solubility:
4.31e-01 g/l

# Primary_Accession_No:
DB03199

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936605

# PubChem_Substance_ID:
46506149

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01358

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC[C@@]1(O)C[C@H](O[C@@H]2C[C@@H]([C@@H](O)[C@H](C)O2)N(C)C)C2=C(O)C3=C(C(O)=C2[C@@H]1C(=O)OC)C(=O)C1=CC=CC(OC)=C1C3=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:01 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L13453

# Drug_Target_1_GenBank_ID_Protein:
295169

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
dnrK

# Drug_Target_1_Gene_Sequence:
>1071 bp
ATGACAGCCGAACCGACGGTCGCGGCCCGGCCGCAGCAGATCGACGCCCTCAGGACCCTG
ATCCGCCTCGGAAGCCTGCACACGCCCATGGTCGTCCGGACGGCCGCCACCCTGCGGCTC
GTCGACCACATCCTGGCCGGGGCCCGCACCGTGAAGGCCCTGGCGGCCAGGACAGACACC
CGGCCGGAAGCACTCCTGCGACTGATCCGCCACCTGGTGGCGATCGGACTGCTCGAGGAG
GACGCACCGGGCGAGTTCGTCCCGACCGAGGTCGGCGAGCTGCTCGCCGACGACCACCCA
GCCGCGCAGCGTGCCTGGCACGACCTGACGCAGGCCGTGGCGCGCGCCGACATCTCCTTC
ACCCGCCTCCCCGACGCCATCCGTACCGGCCGCCCCACGTACGAGTCCATCTACGGCAAG
CCGTTCTACGAGGACCTGGCCGGCCGCCCCGACCTGCGCGCGTCCTTCGACTCGCTGCTC
GCCTGCGACCAGGACGTCGCCTTCGACGCTCCGGCCGCCGCGTACGACTGGACGAACGTC
CGGCATGTGCTCGACGTGGGTGGCGGCAAGGGTGGTTTCGCCGCGGCCATCGCGCGCCGG
GCCCCGCACGTGTCGGCCACCGTGCTGGAGATGGCGGGCACCGTGGACACCGCCCGCTCC
TACCTGAAGGACGAGGGCCTCTCCGACCGTGTCGACGTCGTCGAGGGGGACTTCTTCGAG
CCGCTGCCCCGCAAGGCGGACGCGATCATCCTCTCTTTCGTCCTCCTCAACTGGCCGGAC
CACGACGCCGTCCGGATCCTCACCCGCTGCGCCGAGGCCCTGGAGCCCGGCGGGCGCATC
CTGATCCACGAGCGCGACGACCTCCACGAGAACTCGTTCAACGAACAGTTCACAGAGCTC
GATCTGCGGATGCTGGTCTTCCTCGGCGGTGCCCTGCGCACCCGCGAGAAGTGGGACGGC
CTGGCCGCGTCGGCGGGCCTCGTGGTCGAGGAGGTGCGGCAACTGCCGTCGCCGACCATC
CCGTACGACCTCTCGCTCCTCGTCCTTGCCCCCGCGGCCACCGGCGCCTGA

# Drug_Target_1_General_Function:
Secondary metabolites biosynthesis, transport and catabolism

# Drug_Target_1_General_References:
7601857	Madduri K, Hutchinson CR: Functional characterization and transcriptional analysis of a gene cluster governing early and late steps in daunorubicin biosynthesis in Streptomyces peucetius. J Bacteriol. 1995 Jul;177(13):3879-84.
8509343	Madduri K, Torti F, Colombo AL, Hutchinson CR: Cloning and sequencing of a gene encoding carminomycin 4-O-methyltransferase from Streptomyces peucetius and its expression in Escherichia coli. J Bacteriol. 1993 Jun;175(12):3900-4.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3117

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
38783

# Drug_Target_1_Name:
Carminomycin 4-O-methyltransferase

# Drug_Target_1_Number_of_Residues:
356

# Drug_Target_1_PDB_ID:
1TW3

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00891	Methyltransf_2

# Drug_Target_1_Protein_Sequence:
>Carminomycin 4-O-methyltransferase
MTAEPTVAARPQQIDALRTLIRLGSLHTPMVVRTAATLRLVDHILAGARTVKALAARTDT
RPEALLRLIRHLVAIGLLEEDAPGEFVPTEVGELLADDHPAAQRAWHDLTQAVARADISF
TRLPDAIRTGRPTYESIYGKPFYEDLAGRPDLRASFDSLLACDQDVAFDAPAAAYDWTNV
RHVLDVGGGKGGFAAAIARRAPHVSATVLEMAGTVDTARSYLKDEGLSDRVDVVEGDFFE
PLPRKADAIILSFVLLNWPDHDAVRILTRCAEALEPGGRILIHERDDLHENSFNEQFTEL
DLRMLVFLGGALRTREKWDGLAASAGLVVEEVRQLPSPTIPYDLSLLVLAPAATGA

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the conversion of carminomycin to daunorubicin

# Drug_Target_1_SwissProt_ID:
Q06528

# Drug_Target_1_SwissProt_Name:
CM4T_STRPE

# Drug_Target_1_Synonyms:
COMT
EC 2.1.1.-

# Drug_Target_1_Theoretical_pI:
4.95

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03199
